Article Details
Retrieved on: 2025-10-02 14:55:09
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Regulatory documents show how 89bio's board pushed Roche hard for a deal valued at $20 per share in upfront and milestone payments.
Article found on: www.biospace.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here